全文获取类型
收费全文 | 2767篇 |
免费 | 149篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 90篇 |
妇产科学 | 45篇 |
基础医学 | 284篇 |
口腔科学 | 263篇 |
临床医学 | 244篇 |
内科学 | 582篇 |
皮肤病学 | 19篇 |
神经病学 | 154篇 |
特种医学 | 84篇 |
外科学 | 463篇 |
综合类 | 21篇 |
一般理论 | 1篇 |
预防医学 | 354篇 |
眼科学 | 14篇 |
药学 | 211篇 |
中国医学 | 1篇 |
肿瘤学 | 84篇 |
出版年
2023年 | 5篇 |
2022年 | 7篇 |
2021年 | 43篇 |
2020年 | 31篇 |
2019年 | 45篇 |
2018年 | 50篇 |
2017年 | 41篇 |
2016年 | 46篇 |
2015年 | 42篇 |
2014年 | 75篇 |
2013年 | 150篇 |
2012年 | 157篇 |
2011年 | 174篇 |
2010年 | 89篇 |
2009年 | 80篇 |
2008年 | 186篇 |
2007年 | 200篇 |
2006年 | 180篇 |
2005年 | 200篇 |
2004年 | 190篇 |
2003年 | 198篇 |
2002年 | 179篇 |
2001年 | 39篇 |
2000年 | 21篇 |
1999年 | 51篇 |
1998年 | 48篇 |
1997年 | 43篇 |
1996年 | 38篇 |
1995年 | 21篇 |
1994年 | 24篇 |
1993年 | 27篇 |
1992年 | 22篇 |
1991年 | 21篇 |
1990年 | 15篇 |
1989年 | 6篇 |
1988年 | 11篇 |
1987年 | 8篇 |
1986年 | 7篇 |
1985年 | 17篇 |
1984年 | 17篇 |
1983年 | 12篇 |
1982年 | 19篇 |
1981年 | 23篇 |
1980年 | 14篇 |
1979年 | 10篇 |
1978年 | 12篇 |
1976年 | 7篇 |
1975年 | 6篇 |
1974年 | 5篇 |
1966年 | 4篇 |
排序方式: 共有2942条查询结果,搜索用时 0 毫秒
41.
Matti Rautalahti Lea Hyvönen Demetrius Albanes Anna‐Maija Lampi Pekka Koivistoinen Jarmo Virtamo 《Nutrition and cancer》2013,65(3-4):247-251
The effect of sampling site and proximity of malignant tumor on the relative fatty acid composition of human breast adipose tissue was studied in 10 cases of breast cancer. The four anatomic quadrants of breast did not statistically significantly differ from each other in relation to any of the 30 fatty acids studied. Proximity of the malignant tumor did not affect the relative fatty acid composition of fat when compared with more distant sampling sites. Representative samples of breast adipose tissue for fatty acid composition analysis can be obtained from tissue adjacent to the tumor. 相似文献
42.
Eetu Heervä Laura Huilaja Pekka Leinonen Sirkku Peltonen Juha Peltonen 《Calcified tissue international》2014,94(6):608-612
This is the first prospective follow-up study to describe the effects of oral alendronate medication on neurofibromatosis 1 (NF1)-related osteoporosis. NF1 is a neurocutaneous skeletal syndrome associated with increased fracture risk and high frequency of osteopenia and osteoporosis. Alendronate is a bisphosphonate drug which inhibits the function of bone-resorbing osteoclasts, ultimately leading to an increase in bone mineral density (BMD) and reduction in fracture risk. However, in vitro studies have shown that NF1 osteoclasts display insensitivity to apoptotic signals caused by bisphosphonates. Our aim was to monitor the effects of alendronate medication in patients with NF1. Five men and one woman, aged 28–76 years, with NF1-related osteoporosis were enrolled to the study. Study participants did not have other conditions and were not taking any medication known to affect bone. The medication included a weekly dose of 70 mg alendronate and a daily 20 μg vitamin D supplementation. After 23 months of follow-up, BMD was increased in five out of six patients, but the increase was not statistically significant. Serum levels of the bone turnover markers CTX and PINP were reduced, suggesting slower bone remodeling, as expected. An unexpected result was that serum levels of the osteoclast activity marker TRAP5b did not change during the follow-up. One new stress fracture of the tibia was documented during the alendronate therapy. Even though the study group was small, the findings of the current study (one new fracture and one patient with decreased BMD) call for a larger study to assess the efficacy of bisphosphonates in NF1-related osteoporosis. 相似文献
43.
Minxin Wei Jari Laurikka Pekka Kuukasjärvi Erkki Pehkonen Seppo Kaukinen Seppo Laine 《Scandinavian cardiovascular journal : SCJ》2013,47(6):345-349
Objective : The purpose of the present study was to establish whether pump prime aprotinin could influence soluble adhesion molecules in patients undergoing elective coronary artery bypass surgery. Design : Thirty patients admitted for first-time elective coronary artery bypass surgery were randomized into control or aprotinin groups. Patients in the aprotinin group received 280 mg of aprotinin in the pump prime. Plasma levels of soluble adhesion molecules were analyzed perioperatively. Results : There were no significant changes in plasma sE-selectin after the operation in either group. Plasma sP-selectin increased significantly up to 20 h after reperfusion to the myocardium. Plasma sICAM-1 decreased in the early stage after cardiopulmonary bypass (CPB), then recovered at 4 h after reperfusion and a significant increase in sICAM-1 was observed 20 h later. There were no significant differences between the groups in postoperative changes in sP-selectin ( p = 0.21) and sICAM-1 ( p = 0.91). Conclusion : Pump prime aprotinin did not influence plasma levels of E-selectin, P-selectin and ICAM-1 in the present patients. The present results do not support the concept of an anti-inflammatory effect of pump prime aprotinin. 相似文献
44.
45.
46.
47.
48.
Various bone proteins and growth factors in specific concentrations are required for bone formation. If the body cannot produce sufficient quantities of these factors, bone trauma can be healed with an implant that includes the required factors in a carrier. This study was designed to evaluate various calcium salt candidates that can be used as carrier with reindeer bone protein extract to induce ectopic bone formation in the muscle pouch model of mouse. The bone protein extract was either impregnated into the disc form of carrier or mixed with carrier powder before implantation. The radiographic analysis indicated increased bone formation in all of the active groups containing the bone protein extract compared to the controls within 21 days follow-up. The highest bone formation was seen in the group with calcium sulfate with stearic acid where new bone and calcified cartilage were clearly visible. The greatest bone formation occurred in the groups that had bone protein extract readily available. This indicates that the bone forming factors in sufficient concentrations are required at the early stage of bone formation. The calcium sulfate with stearic acid was the most suitable and effective carrier for reindeer bone protein extract. 相似文献
49.
50.
BACKGROUND. The activity of cyclooxygenase-2 (COX-2) is increased in inflammation and in several cancer types. We investigated the expression of COX-2, cyclooxygenase-1 (COX-1), nitric oxide synthase-2 (NOS-2) and nitric oxide synthase-3 (NOS-3) in normal proliferative and secretory human endometrium, and in endometrial adenocarcinoma. METHODS. Human endometrium was collected at hysterectomy. Seven samples were in proliferative and 11 samples in secretory stage. Twelve specimens from endometrial carcinoma were collected, as well. Immunohistochemistry was used to investigate the expression of COX-1, COX-2, NOS-2 and NOS-3. RESULTS. COX-2 immunostaining was detected in most specimens of normal proliferative glandular epithelium (86%) and of endometrial carcinomas (92%). COX-2 staining was often detected in cancer cells on the border areas of the tumour and on the areas of invasive growth. Staining for COX-2 was seen in proliferative glands usually only in the basal layer of the endometrium. NOS-2 was usually absent or negligible in proliferative endometrial glands and also in the cancer cells of endometrial adenocarcinomas. No staining for either COX-2 or NOS-2 was seen in specimens of secretory glandular epithelium. The expression of the constitutive COX-1 and NOS-3 was negligible or weak in the glandular epithelium of proliferative and secretory endometrium and in endometrial cancer cells. CONCLUSIONS. The expression of the inducible COX-2 but not of COX-1 is stimulated in the glandular epithelium of proliferative endometrium and in the cancer cells of human endometrial adenocarcinoma, in particular in those in the borders of carcinoma and spreading into lymphatic vessels. 相似文献